Inactive Instrument

Other languages RLS Global AB (publ)

Equities

RLS Global to Submit Bankruptcy Application	Nov. 20
RLS Global ansöker om konkurs	Nov. 20
RLS Global Abandons ChloraSolv Partnership with ConvaTec Group	Nov. 10
RLS Global Launches Strategic Review of Options for ChloraSolv Commercialization	Nov. 10
RLS Global initiates strategic review process aiming to commercialize ChloraSolv	Nov. 09
RLS Global Initiates Strategic Review Process Aiming to Commercialize ChloraSolv	Nov. 09
RLS Global and Convatec have agreed to terminate collaboration agreement	Nov. 09
RLS Global and Convatec Agree to Terminate Collaboration Agreement	Nov. 09
RLS Global Enrols First Patient in Clinical Trial on Pressure Ulcers	23-09-06
First patient included in new clinical investigation on pressure ulcers	23-09-06
RLS Global AB Announces First Patient Included in New Clinical Investigation on Pressure Ulcers	23-09-06
ChloraSolv recommended for UK CA certification required for UK market after Brexit	23-09-01
RLS Global Q2 2023 - Uncertain future	23-08-28
RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL-JUNE 2023	23-08-25
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25
RLS Global Receives SEK5 Million Loan	23-08-25
RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0	23-08-24
RLS Global Names New CFO	23-08-22
RLS Global appoints Torbjörn Sannerstedt as new Chief Financial Officer	23-08-22
RLS Global AB Announces Chief Financial Officer Changes	23-08-22

No results for this search